Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

ACADIA Pharmaceuticals

ACADIA Pharmaceuticals
1993 FOUNDED
PUBLIC STATUS
401-500 EMPLOYEES
ACAD STOCK SYMBOL
$25.79 SHARE PRICE (As of Monday Closing)
Description

Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

Ownership Status
Publicly Held
Financing Status
Failed Transaction (M&A)
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • 3611 Valley Centre Drive
  • Suite 300
  • San Diego, CA 92130
  • United States

+1 (858) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore ACADIA Pharmaceuticals’s full profile, request a free trial.

ACADIA Pharmaceuticals Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$12.77 - $28.67 $3.72B $26.00 -$2.10 1.09M 144M

ACADIA Pharmaceuticals Financials Summary

In Thousands,
USD
TTM
31-Mar-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 3,389,722 1,981,923 3,210,796 3,277,791
Revenue 237,898 223,807 124,901 17,331
EBITDA (279,299) (246,279) (289,697) (270,987)
Net Income (276,200) (245,192) (289,403) (271,393)
Total Assets 501,105 540,202 384,506 561,153
Public Fundamental Data provided by Morningstar, Inc. disclaimer

ACADIA Pharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore ACADIA Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

ACADIA Pharmaceuticals Competitors (32)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
SAGE Therapeutics Formerly VC-backed Cambridge, MA 000 00000 00000000000 00000
000000000 00000000 Corporation Pasadena, CA 00 00.000 000000000 00.000
00 0000000 Formerly Accelerator/Incubator backed Paris, France 000 000.00 000000000 000.00
0000000 0000000000 Formerly VC-backed Cambridge, MA 0000 00.000 00000000 00.000
0000000000000 0000 Formerly VC-backed Cambridge, MA 00 00000 00000000 00000
To view this company’s complete list of competitors, request access »

ACADIA Pharmaceuticals Executive Team (16)

Name Title Board
Seat
Contact
Info
Stephen Davis JD Chief Executive Officer, President & Board Member
Ryan Brown JD Vice President & Chief Compliance Officer
Glen Baity JD Corporate Secretary, Executive Vice President & Board Member
Michael Yang Chief Commercial Officer & Executive Vice President
Terrence Moore Executive Vice President & Board Member

6 Former Executives

You’re viewing 5 of 16 executives. Get the full list »

ACADIA Pharmaceuticals Board Members (12)

Name Representing Role Since Contact
Info
000000 000000 ACADIA Pharmaceuticals Board Member 000 0000
00000 00000 ACADIA Pharmaceuticals Board Member 000 0000
0000000 000000 00.0 Self Chairman & Board Member 000 0000
00000000 00000 ACADIA Pharmaceuticals Executive Vice President & Board Member 000 0000
0000 00000 00 Self Chief Financial Officer, Executive Vice President and Board Member 000 0000

7 Former Board Members

You’re viewing 5 of 12 board members. Get the full list »